28.04.2016 17:00:01
|
DGAP-Stimmrechtsanteile: Probiodrug AG
DGAP-PVR: Correction of a release from 11.11.2014, 13:10 CET/CEST - Probiodrug AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Correction of publication of notification of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)
3.1
JPMorgan Asset Management (UK) Limited, London, United Kingdom, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion exceeded the threshold of 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on October 30, 2014, and that its voting rights proportion in Probiodrug AG amounted to 3.87% (corresponding to 260,000 voting rights). 3.87% (corresponding to 260,000 voting rights) are to be attributed to JPMorgan Asset Management (UK) Limited pursuant to sec. 22 para. 1 sentence 1 no. 6 WpHG.
Halle (Saale), in April 2016
The Management
28.04.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Probiodrug AG
28.04.2016 17:00
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Probiodrug AG
Halle (Saale), Germany
Handelsregister: Amtsgericht Stendal, HRB 213719
(Commercial Register: Local Court of Stendal, HRB 213719)
ISIN: DE0007921835
Publication pursuant to sec. 26 para 1 WpHG (Wertpapierhandelsgesetz -
German Securities Trading Act)
Correction of publication of notification of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)
3.1
JPMorgan Asset Management (UK) Limited, London, United Kingdom, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion exceeded the threshold of 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on October 30, 2014, and that its voting rights proportion in Probiodrug AG amounted to 3.87% (corresponding to 260,000 voting rights). 3.87% (corresponding to 260,000 voting rights) are to be attributed to JPMorgan Asset Management (UK) Limited pursuant to sec. 22 para. 1 sentence 1 no. 6 WpHG.
Halle (Saale), in April 2016
The Management
28.04.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de
--------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Probiodrug AGmehr Nachrichten
Keine Nachrichten verfügbar. |